Continuous Testosterone Tracking Experiment – Ask The Doc

A weekly live Q and A format is described, and an excerpt focuses on hormone monitoring details. A participant explains a twice weekly injection schedule spaced about three and a half days apart. The timing is specified as Tuesday evening and Saturday morning to split the week evenly. To understand peaks and troughs, four morning blood tests are taken between the injections. One draw uses a full ABCDS™ panel ordered through a clinician, and others are narrower repeats. The aim is to map total and free testosterone values from twelve hours after dosing to trough. The report suggests total testosterone stayed unexpectedly flat across the interval with one dip day. A possible explanation offered is measurement variability rather than a true physiologic swing.

The conversation compares prior gel use with injections and notes that free values were once lower. Dose history is mentioned, including a prior weekly amount around one hundred twenty five milligrams. A current weekly dose around one hundred fifteen milligrams is described during the tracking campaign. The discussion then pivots to hematocrit and hemoglobin, described as drifting upward historically. A screening style approach is used, asking about embolism, hypertension, cardiac disease, and strokes. Polycythemia vera is mentioned as a distinct disease category, while stating the case does not match it. The segment cautions against managing therapy by chasing single cutoffs without broader patient context. It stresses that symptoms and trends matter more than isolated numbers copied from lab reference ranges.

Iron studies are brought into the discussion, and ABCDS™ are referenced with D tied to iron deposition. Ferritin is discussed as a marker that can rise, and phlebotomy is mentioned in severe deposition cases. Sleep apnea and diet are discussed as contributors that can influence hemoglobin and hematocrit readings. The segment explains that hemoglobin molecules carry oxygen and contain elemental iron at their core. It argues that red blood cell values cannot be interpreted without considering iron availability and drivers. Later remarks note that some variation is statistical and does not automatically signal a dangerous problem. A practical takeaway is to use consistent timing, repeated measurements, and full context for decisions. The closing frames tracking as a tool to reduce guesswork when adjusting hormones and monitoring safety.